114 related articles for article (PubMed ID: 2115456)
1. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair.
Barlati S; Marchina E; Quaranta CA; Vigasio F; Semeraro F
Exp Eye Res; 1990 Jul; 51(1):1-9. PubMed ID: 2115456
[TBL] [Abstract][Full Text] [Related]
2. Determination of plasminogen activator activities in normal and pathological human tears. The significance of tear plasminogen activators in the inflammatory and traumatic lesions of the cornea and the conjunctiva.
Berta A; Tözsér J; Holly FJ
Acta Ophthalmol (Copenh); 1990 Oct; 68(5):508-14. PubMed ID: 2275342
[TBL] [Abstract][Full Text] [Related]
3. Elevation of tear fluid plasmin in corneal disease.
Tervo T; Salonen EM; Vahen A; Immonen I; van Setten GB; Himberg JJ; Tarkkanen A
Acta Ophthalmol (Copenh); 1988 Aug; 66(4):393-9. PubMed ID: 2973722
[TBL] [Abstract][Full Text] [Related]
4. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
5. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase.
Marchina E; Barlati S
Int J Biochem Cell Biol; 1996 Oct; 28(10):1141-50. PubMed ID: 8930138
[TBL] [Abstract][Full Text] [Related]
6. Plasmin and plasminogen activator activities in tear fluid during corneal wound healing after anterior keratectomy.
van Setten GB; Salonen EM; Vaheri A; Beuerman RW; Hietanen J; Tarkkanen A; Tervo T
Curr Eye Res; 1989 Dec; 8(12):1293-8. PubMed ID: 2534068
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator and its inhibitor in the experimental corneal wound.
Tervo T; Tervo K; van Setten GB; Virtanen I; Tarkkanen A
Exp Eye Res; 1989 Mar; 48(3):445-9. PubMed ID: 2494049
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
Brown JM; Watanabe K; Cohen RL; Chambers DA
Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
[TBL] [Abstract][Full Text] [Related]
9. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo.
Grøndahl-Hansen J; Lund LR; Ralfkiaer E; Ottevanger V; Danø K
J Invest Dermatol; 1988 Jun; 90(6):790-5. PubMed ID: 3131440
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator in human tears.
Stevens JD; Marshall JM; Benjamin L; Cederholm-Williams SA; Bron AJ
Eye (Lond); 1992; 6 ( Pt 6)():653-8. PubMed ID: 1289146
[TBL] [Abstract][Full Text] [Related]
11. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
Karlan BY; Clark AS; Littlefield BA
Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
Gissler HM; Frank R; Kramer MD
Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
[TBL] [Abstract][Full Text] [Related]
13. Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study.
Tripathi RC; Tripathi BJ; Park JK
Exp Eye Res; 1990 Nov; 51(5):545-52. PubMed ID: 2123459
[TBL] [Abstract][Full Text] [Related]
14. Effect of heat on the distribution of fluorescently labeled plasminogen and plasminogen activators in bovine skim milk.
Wang L; Mauer LJ
J Food Sci; 2008 Apr; 73(3):C185-90. PubMed ID: 18387097
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activation in healing human wounds.
Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
Rijken DC; Wijngaards G; Welbergen J
J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlation with the PA/plasmin system in septic arthritis of the knee.
Hsieh YS; Yang SF; Lue KH; Lu KH
Clin Orthop Relat Res; 2006 Jun; 447():172-8. PubMed ID: 16505706
[TBL] [Abstract][Full Text] [Related]
18. Tear plasminogen activators--indicators of epithelial cell destruction. The effect of scraping, n-heptanol debridement, and alkali burn of the cornea on the plasminogen activator activity of rabbit tears.
Berta A; Holly FJ; Tözsér J; Holly TF
Int Ophthalmol; 1991 Nov; 15(6):363-9. PubMed ID: 1778666
[TBL] [Abstract][Full Text] [Related]
19. [The cornea: stasis and dynamics].
Nishida T
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator activity and plasminogen independent amidolytic activity in tear fluid from healthy persons and patients with anterior segment inflammation.
Tözsér J; Berta A; Punyiczki M
Clin Chim Acta; 1989 Aug; 183(3):323-31. PubMed ID: 2805358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
